Лого Српског лекарског друштва

Часопис Српског лекарског друштва

Српски архив за целокупно лекарство

Serbian Archives of Medicine

еКорпус – библиографски запис

Novel PANK2 mutation identified in a patient with pantothenate kinase-associated neurodegeneration

НОВА МУТАЦИЈА У ГЕНУ PANK2 КОД БОЛЕСНИКА СА НЕУРОДЕГЕНЕРАЦИЈОМ УДРУЖЕНОМ СА ПАНТОТЕНАТ-КИНАЗОМ

Марина Светел; Ивана Новаковић; Светлана Томић; Никола Кресојевић; Владимир Костић

Часопис
Serbian Archives of Medicine
Објављено
Srp Arh Celok Lek. 2020;148(3–4):203–206.
Врста рада
CASE REPORTS

Abstract

Introduction Pantothenate kinase-associated neurodegeneration (PKAN) is a rare, recessively inherited disorder caused by mutations in the pantothenate kinase 2 (PANK2) gene on chromosome 20p13. The objective of this report is to present a patient with atypical PKAN with the novel heterozygous PANK2 mutation.

Case outline We present a 32-year-old female who had disease onset at the age 20 (depression, speech, chewing problems and backward falls) with progressive course. Neurological examination revealed hypomimia, risus sardonicus, dysphagia, tachylalia and severe dystonic dysarthria, moderate arms, legs, and jaw-opening dystonia, postural instability, urge incontinence, and decreased visual acuity. Brain magnetic resonance imaging revealed iron accumulation in the bilateral globus pallidus and putamen (“eye-of-the-tiger”), a radiological finding pathognomonic for PKAN. Genetic analysis revealed known mutation p.T528M (c.1583C>T) in exon 6, and novel p.Y405D (c.1213T>G) in exon 3 of the PANK2 gene. In silico analyses strongly suggested this mutation to be pathogenic.

Conclusion We report a patient with PKAN, and novel substitution p.Y405D (c.1213T>G) in PANK2 that has not been previously described in PKAN patients.

Keywords: neurodegeneration with brain iron accumulation; pantothenate kinase-associated neurodegeneration; PANK2